These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Microencapsulated Saccharomyces cerevisiae column bioreactor for potential use in renal failure uremia.
    Author: Coussa RG, Shah S, Jain P, Martoni C, Bhathena J, Malhotra M, Prakash S.
    Journal: Artif Cells Blood Substit Immobil Biotechnol; 2012 Feb; 40(1-2):103-12. PubMed ID: 22288841.
    Abstract:
    A novel bioreactor containing viable APA microencapsulated yeast cells was designed. Rat plasma was used for perfusion. Yeast cell loading and perfusion flow rate were studied to maximize urea removal. An increase in column loading from 25% to 100%, increased urea removal from 5.67 ± 1.34% to 30.45 ± 0.48%. An increase in flow rate from low to high, increased urea removal from 30.46% to 40.4%. At 100% column loading and high flow rate, the creatinine and phosphate concentrations decreased by 22% and 10%, respectively, while ammonia concentrations increased by 58.9% (p < 0.05). Our in-vitro perfusion study demonstrates that microencapsulated yeast cells can remove urea efficiently.
    [Abstract] [Full Text] [Related] [New Search]